CANY
INSM icon

Caxton Associates (New York)’s Insmed INSM Stock Holding History

Caxton Associates (New York)’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$530K Sell
7,678
-591
-7% -$42.6K 0.02% 319
2024
Q3 		$604K Buy
+8,269
New +$610K 0.02% 337

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Caxton Associates (New York)'s INSM Position: Q4 2024 in Review

Caxton Associates (New York) reduced its Insmed (INSM) stake by 7.1% in Q4 2024, selling an estimated $42.6K and leaving 7,678 shares worth $530K. The position accounts for 0.02% of the portfolio, ranked #319.

Caxton Associates (New York) first reported a position in INSM in Q3 2024 and has held it in 2 quarters since. The position peaked at $604K in Q3 2024. 438 funds tracked by Wall St. Rank hold INSM as of Q4 2024.

  • Caxton Associates (New York) held 7,678 shares of Insmed worth $530K as of Q4 2024.
  • Caxton Associates (New York) sold 591 Insmed shares in Q4 2024, an estimated $42.6K.
  • Insmed made up 0.02% of Caxton Associates (New York)'s portfolio in Q4 2024, its #319 holding.
  • Caxton Associates (New York) first reported a position in Insmed in Q3 2024 and has held it in 2 quarters since.
  • Caxton Associates (New York)'s Insmed position peaked at $604K in Q3 2024.
  • 438 funds tracked by Wall St. Rank held Insmed as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.